Article Text

other Versions

PDF
Research Paper
Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy
  1. J C van den Bergen1,
  2. S M Schade van Westrum2,3,
  3. L Dekker4,
  4. A J van der Kooi2,
  5. M de Visser2,
  6. B H A Wokke1,
  7. C S Straathof1,
  8. M A Hulsker5,
  9. A Aartsma-Rus5,
  10. J J Verschuuren1,
  11. H B Ginjaar6
  1. 1Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
  2. 2Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
  3. 3Department of Neurology, Martini Hospital, Groningen, The Netherlands
  4. 4Department of Cardiology, Catharina Medical Center, Eindhoven, The Netherlands
  5. 5Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
  6. 6Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
  1. Correspondence to J C van den Bergen,  Department of Neurology, Leiden University Medical Center, Albinusdreef 2, K5-Q-110, Leiden 2333 ZA, The Netherlands; j.c.van_den_bergen{at}lumc.nl

Abstract

Objective Duchenne and Becker muscular dystrophy (DMD/BMD) are both caused by mutations in the DMD gene. Out-of-frame mutations in DMD lead to absence of the dystrophin protein, while in-frame BMD mutations cause production of internally deleted dystrophin. Clinically, patients with DMD loose ambulance around the age of 12, need ventilatory support at their late teens and die in their third or fourth decade due to pulmonary or cardiac failure. BMD has a more variable disease course. The disease course of patients with BMD with specific mutations could be very informative to predict the outcome of the exon-skipping therapy, aiming to restore the reading-frame in patients with DMD.

Methods Patients with BMD with a mutation equalling a DMD mutation after successful exon skipping were selected from the Dutch Dystrophinopathy Database. Information about disease course was gathered through a standardised questionnaire. Cardiac data were collected from medical correspondence and a previous study on cardiac function in BMD.

Results Forty-eight patients were included, representing 11 different mutations. Median age of patients was 43 years (range 6–67). Nine patients were wheelchair users (26–56 years). Dilated cardiomyopathy was present in 7/36 patients. Only one patient used ventilatory support. Three patients had died at the age of 45, 50 and 76 years, respectively.

Conclusions This study provides mutation specific data on the course of disease in patients with BMD. It shows that the disease course of patients with BMD, with a mutation equalling a ‘skipped’ DMD mutation is relatively mild. This finding strongly supports the potential benefit of exon skipping in patients with DMD.

  • Muscular Dystrophy
  • Muscle Disease
  • Dystrophin

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles